- Volition to Take Part in Nu.Q® Vet Commercial Strategy Webinar
- Volition Announces Expansion of Availability of the Nu.Q® Vet Cancer Test Through IDEXX's Reference Laboratory Network
- Volition Issues Business Review 2022
- VolitionRx Limited Announces Third Quarter 2022 Financial Results and Business Update
- Volition Announces Clinical Research Study with Oncovet
- Volition to Participate in a Lung Cancer Screening Study in France
- VolitionRx Limited Schedules Third Quarter 2022 Earnings Conference Call and Business Update
VolitionRX Ltd (VNRX:ASQ) closed at 2.23, 70.23% above the 52 week low of 1.31 set on Sep 29, 2022.
1.31Sep 29 20223.30Mar 29 2022
Markit short selling activity
|Market cap||135.18m USD|
|EPS (TTM)||-0.5721 |
Data delayed at least 15 minutes, as of Feb 03 2023 21:10 GMT.